期刊文献+

吸入麻醉在肥胖患者中的应用 被引量:1

下载PDF
导出
摘要 肥胖不仅增加多种疾病的发病率,也可加重麻醉的风险。全面理解肥胖患者在病理生理、药理特点及其与不同吸入麻醉药的相互影响,能使麻醉医生更好得实施吸入麻醉。
出处 《中国实验诊断学》 2015年第7期1220-1222,共3页 Chinese Journal of Laboratory Diagnosis
  • 相关文献

参考文献9

  • 1Rudin Domi, Haki Labo. Anesthetic challenges in the obese pa- tient[J]. J Anesth, 2012,26 : 758.
  • 2Whitlock G, Lewingkton S, Sherliker P, et al. Body mass index and cause specific mortality in 900 000 adults: collaborative ana- lyses of 57 prospective studies [J]. Lancet, 2009, 373 (9669) : 1083.
  • 3赵青,张抒扬.肥胖症与心血管疾病[J].中国医学科学院学报,2012,34(4):431-436. 被引量:13
  • 4Edmond I Eger II, Lawrence J. Saidman. Illustration of inhaled anesthetic uptake,including intertissue diffusion to and from fat f-J3. Anesth Analg, 2005,100 : 1020.
  • 5Lemmens HJ, Saidman LJ, Eger EI 2nd, et al. Obesity modestly affects inhaled anesthetic kinetic in humans[J]. Anesth Analg, 2008,107(6) :1864.
  • 6Vallejo MC, Sah N, Phelps AL, et al. Desflurane versus sevoflu- rane for laparoscopic gastroplasty in morbidly obese patients[J]. J Clin Anesth,2007,19:3.
  • 7Zeidan A, Mazoit JX. Minimal alveolar concentration of sevoflu- rane for maintaining bispectral index below 50 in morbidly obese patients[J]. Acta Anaesthesiol Scand. , 2013,57 (4) : 474.
  • 8POs6 TKesek D, Wins0 O et al. Volatile rapid sequence induc- tion in morbidly obese patients[J ]. Eur J Anesth, 2011,28 ( 11 ) : 781.
  • 9Juvin P, Vadam C, Malek L, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study [ J ]. Anesth Analg, 2000,1 : 714.

二级参考文献11

  • 1武阳丰,马冠生,胡永华,李艳平,李贤,崔朝辉,陈春明,孔灵芝.中国居民的超重和肥胖流行现状[J].中华预防医学杂志,2005,39(5):316-320. 被引量:567
  • 2Whitlock G,Lewington S,Sherliker P,et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies [J]. Lancet,2009,373(9669):1083-1096.
  • 3Schorr U,Blaschke K,Turan S,et al. Relationship between angiotensinogen,leptin and blood pressure levels in young normotensive men [J]. J Hypertens,1998,16(10):1475-1480.
  • 4Kim JA,Montagnani M,Koh KK,et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms [J]. Circulation,2006,113(15):1888-1904.
  • 5Aróstegui JI. Pathophysiological mechanisms underlying cryo-pyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome [J]. Med Clin (Barc),2011,136(Suppl 1):22-28.
  • 6Coccheri S. Antiplatelet drugs—do we need new options? With a reappraisal of direct thromboxane inhibitors [J]. Drugs,2010,70(7):887-908.
  • 7Mehta L,Devlin W,Mccullough PA,et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction [J]. Am J Cardiol,2007,99(7):906-910.
  • 8Oreopoulos A,Mcalister FA,Kalantar-Zadeh K,et al. The relationship between body mass index,treatment,and mortality in patients with established coronary artery disease: a report from APPROACH [J]. Eur Heart J,2009,30(21):2584-2592.
  • 9Dokras A,Jagasia DH,Maifeld M,et al. Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome [J]. Fertil Steril,2006,86(6):1702-1709.
  • 10Blumenthal JA,Sherwood A,Gullette EC,et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular,metabolic,and hemodynamic functioning [J]. Arch Intern Med,2000,160(13):1947-1958.

共引文献12

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部